QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: Statins and Tendon Rupture—Signal Evaluation

Test your understanding of the concepts covered by Statins and Tendon Rupture: A Signal Evaluation.

Question 1 of 10Pass mark: 80%

Question 1 of 10 What does the absence of consistent effects across sex, age, treatment duration and dose in the large cohort study imply?
Question 2 of 10 Which causal structure best represents confounding by the underlying lipid disorder in this signal?
Question 3 of 10 What was the most appropriate interpretation of the 2009 case-control study's overall estimate of OR 1.10 (95% CI 0.57–2.13)?
Question 4 of 10 Why are spontaneous reports and case reports particularly useful in the early evaluation of this association?
Question 5 of 10 Which finding would most strengthen the case for a substantial population-level causal effect of statins on tendon rupture?
Question 6 of 10 What is the principal limitation of the French pharmacovigilance series for estimating the incidence of statin-associated tendon rupture?
Question 7 of 10 Why should tendinopathy and complete tendon rupture not be treated as interchangeable outcomes in a signal assessment?
Question 8 of 10 What is the most defensible overall pharmacovigilance conclusion regarding statins and tendon rupture?
Question 9 of 10 Which conclusion is most appropriate when a large adjusted study is neutral but a well-documented individual case has recurrence after rechallenge?
Question 10 of 10 Which statement best reflects the evidence-weighting principle emphasized by the article?

Select an answer to continue.

QPPV.com